ArticleFrontiers in nutrition2025
Prevention of anemia in children through the consumption of a blueberry and quinoa drink enriched with iron as part of a nutritional program.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To demonstrate the preventive effect against anemia in children by the consumption of a blueberry and quinoa drink enriched with iron as part of a nutritional program. Method: The nutrition program involved 42 children aged 1 to 6 years. They were the children of workers in an agro-industrial company in the city of Trujillo, where they received a blueberry and quinoa drink enriched with iron in the form of ferric pyrophosphate (BQDEI), the content of which in a 200 mL bottle provides 14 mg of Fe. For children without anemia the dose was 1 bottle per day and for children with mild anemia the dose was 2 bottles per day for a period of 6 months. Educational and demonstration sessions were held for parents or caregivers regarding proper food handling, safe water consumption, the importance of personal hygiene and the benefits of a balanced diet rich in iron. In addition, nutritional status evaluation, parasitosis control and ferritin and hemoglobin measurements were performed at the beginning, third and sixth month during the development of the nutritional program. Results: 50% of the children with short stature reached normal height, and 80% of the children's weight/height went from overweight to normal, and these changes were significant. Ferritin concentration in the initial, intermediate and final phases was 40.67 ± 25.20 ng/ml, 49.37 ± 22.41 ng/ml and 54.19 ± 35.38 ng/ml, respectively, showing a significant increase. The hemoglobin concentration was 11.71 ± 0.91 g/dl, 11.83 ± 0.88 g/dl and 11.99 ± 1.03 g/dl, respectively, and the increase was not significant. Conclusion: It was demonstrated that the consumption of BQDEI within a nutritional program contributed to the prevention of anemia in children, by improving hemoglobin and ferritin concentrations. Therefore, it could be implemented in other areas where children are more vulnerable to anemia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.